Latest Breaking News On - Viropharma inc - Page 1 : comparemela.com

Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results

Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Joyce allaireCarole ben maimonFrank nazzarioMichael celanoCompany contactExchange commissionLarimar therapeutics incViropharma incDrug administrationSales at biocryst pharmaceuticalsTherapeutics reports first quarterLicense applicationChief executive officerAtaxia clinical outcomes measures studyVice presidentSenior vice president

Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires

Expansion Deepens Ligand’s Commercial, Clinical and Investment Expertise .

United statesRichard baxterSmithkline beechamKaren reevesTodd davisHarvard business schoolPfizer incHarvard medical schoolBaxter internationalPathogenesis corpWorldwide researchGilead sciencesUniversity of vermont medical schoolAstellas pharma incLigand pharmaceuticalsYale university

Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires

Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesKellie walshBob yedidRichard baxterTavo espinozaTodd davisKaren reevesSmithkline beechamLigand pharmaceuticalsLigand pharmaceuticals incorporated nasdaqUniversity of vermont medical schoolPathogenesis corpAstellas pharma incPrinceton universityAztherapies incGilead sciences

Arbutus Announces CEO, William Collier, to Retire December 31, 2023

Arbutus Announces CEO, William Collier, to Retire December 31, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lisam caperelliMike mcelhaughOncore biopharmaWilliam collierMichaelj mcelhaughBristol myers squibbFrank tortiViropharma incBusiness developmentCo incGilead sciences incMarket analytics at pharmasset incArbutus biopharma corporation nasdaqSecurities exchangeJoseph universityThomas jefferson university

Arbutus Announces CEO, William Collier, to Retire December 31, 2023 - Arbutus Biopharma (NASDAQ:ABUS)

Michael J. McElhaugh, Arbutus Co-founder and COO, to Serve as Interim CEO WARMINSTER, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage

William collierFrank tortiMichaelj mcelhaughLisam caperelliOncore biopharmaMike mcelhaughBristol myers squibbSecurities exchangeBusiness developmentMarket analytics at pharmasset incGilead sciences incThomas jefferson universityArbutus biopharma corporationJoseph universityViropharma incCo inc